Luciano Wannesson

Bellinzona, TI, CH 
Bellinzona, TI, CH 

Overview

Luciano Wannesson practices practicing medicine in Bellinzona, Switzerland.

His clinical expertise encompasses Lung Cancer, B-Cell Lymphoma, EGFR Positive Lung Cancer, Small Cell Lung Cancer (SCLC), and Bone Marrow Transplant.

He is actively involved in clinical research, co-authoring 33 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Bellinzona, TI 6500, Switzerland
Other Locations
Switzerland
Mendrisio, TI, Switzerland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Atezolizumab Plus 8 Gy Single-fraction Radiotherapy for Advanced, Oligoprogressive NSCLC After Upfront Chemotherapy and Anti-PD1 Immunotherapy: A Multicentre, Single Arm, Phase II Study
Atezolizumab Plus 8 Gy Single-fraction Radiotherapy for Advanced, Oligoprogressive NSCLC After Upfront Chemotherapy and Anti-PD1 Immunotherapy: A Multicentre, Single Arm, Phase II Study
Enrollment Status: Terminated
Publish Date: November 18, 2025
Intervention Type: Drug
Study Drug: Atezolizumab
Study Phase: Phase 2
A Multicenter Phase II Clinical Trial of Lurbinectedin (PM01183) in Selected Advanced Solid Tumors
A Multicenter Phase II Clinical Trial of Lurbinectedin (PM01183) in Selected Advanced Solid Tumors
Enrollment Status: Completed
Publish Date: March 02, 2023
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

33 Total Publications

Prognostic value of KRAS G12C in advanced non-small cell lung cancer with high PD-L1 expression treated with upfront immunotherapy: a systematic review and meta-analysis.
Prognostic value of KRAS G12C in advanced non-small cell lung cancer with high PD-L1 expression treated with upfront immunotherapy: a systematic review and meta-analysis.
Journal: Swiss medical weekly
Published: August 13, 2024

Frequently Asked Questions about Luciano Wannesson

Is Luciano Wannesson a top-rated expert for Lung Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Luciano Wannesson is classified as an Experienced expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Luciano Wannesson participate in research or clinical trials?

Yes. Luciano Wannesson has published 33 articles and abstracts on conditions like Lung Cancer. You can view a list of Luciano Wannesson's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Wannesson's expertise for a condition
ConditionClose
        View All 9 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile